PMID- 25587056 OWN - NLM STAT- MEDLINE DCOM- 20150324 LR - 20220330 IS - 1552-5783 (Electronic) IS - 0146-0404 (Print) IS - 0146-0404 (Linking) VI - 56 IP - 2 DP - 2015 Jan 13 TI - Adaptive optics microperimetry and OCT images show preserved function and recovery of cone visibility in macular telangiectasia type 2 retinal lesions. PG - 778-86 LID - 10.1167/iovs.14-15576 [doi] AB - PURPOSE: To evaluate visual function and disease progression in the retinal structural abnormalities of three patients from two unrelated families with macular telangiectasia (MacTel) type 2. METHODS: Adaptive optics scanning laser ophthalmoscopy (AOSLO) and AOSLO microperimetry (AOMP) were used to evaluate the structure and function of macular cones in three eyes with MacTel type 2. Cone spacing was estimated using histogram analysis of intercone distances, and registered spectral-domain optical coherence tomography (SD-OCT) scans were used to evaluate retinal anatomy. AOMP was used to assess visual sensitivity in and around areas of apparent cone loss. RESULTS: Although overall lesion surface area increased, some initially affected regions subsequently showed clear, contiguous, and normally spaced cone mosaics with recovered photoreceptor inner/outer segment (IS/OS) reflectivity (two of two eyes). The AOMP test sites fell within three categories: normal-appearing cones (N), dimly reflecting cones (D), and RPE cell mosaics (R). At N sites, AOMP threshold values (arbitrary units [au]) increased with increasing eccentricity (slope = 0.054 au/degree, r(2) = 0.77). The N thresholds ranged from 0.04 to 0.27 au, D thresholds from 0.04 to 0.33 au, and R thresholds from 0.14 to 1.00 au. There was measurable visual sensitivity everywhere except areas without intact external limiting membrane (ELM) and with diffuse scattering in the IS/OS and posterior tips of the outer segments (PTOS) regions on OCT. CONCLUSIONS: Visual sensitivity and recovery of cone visibility in areas of apparent focal cone loss suggests that MacTel type 2 lesions with a preserved ELM may contain functioning cones with abnormal scattering and/or waveguiding characteristics. (ClinicalTrials.gov number, NCT00254605.). CI - Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc. FAU - Wang, Qinyun AU - Wang Q AD - Duke University School of Medicine, Durham, North Carolina, United States Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States. FAU - Tuten, William S AU - Tuten WS AD - School of Optometry and Vision Science Graduate Group, University of California, Berkeley, Berkeley, California, United States. FAU - Lujan, Brandon J AU - Lujan BJ AD - School of Optometry and Vision Science Graduate Group, University of California, Berkeley, Berkeley, California, United States West Coast Retina Medical Group, San Francisco, California, United States. FAU - Holland, Jennifer AU - Holland J AD - Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States. FAU - Bernstein, Paul S AU - Bernstein PS AD - Department of Ophthalmology, University of Utah Moran Eye Center, Salt Lake City, Utah, United States. FAU - Schwartz, Steven D AU - Schwartz SD AD - Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, California, United States. FAU - Duncan, Jacque L AU - Duncan JL AD - Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States. FAU - Roorda, Austin AU - Roorda A AD - School of Optometry and Vision Science Graduate Group, University of California, Berkeley, Berkeley, California, United States. LA - eng SI - ClinicalTrials.gov/NCT00254605 GR - EY014375/EY/NEI NIH HHS/United States GR - EY022412/EY/NEI NIH HHS/United States GR - L30 EY021930/EY/NEI NIH HHS/United States GR - R01 EY023591/EY/NEI NIH HHS/United States GR - EY002162/EY/NEI NIH HHS/United States GR - EY023591/EY/NEI NIH HHS/United States GR - K23 EY022412/EY/NEI NIH HHS/United States GR - R01 EY014375/EY/NEI NIH HHS/United States GR - P30 EY002162/EY/NEI NIH HHS/United States PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20150113 PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 RN - Osler-rendu-weber syndrome 2 SB - IM MH - Adult MH - Female MH - Fluorescein Angiography MH - Follow-Up Studies MH - Fundus Oculi MH - Humans MH - Male MH - Middle Aged MH - Ophthalmoscopy/methods MH - *Recovery of Function MH - Retinal Cone Photoreceptor Cells/*physiology MH - Telangiectasia, Hereditary Hemorrhagic/*diagnosis/physiopathology MH - Tomography, Optical Coherence/*methods MH - Visual Acuity MH - Visual Field Tests/*methods MH - Visual Fields/*physiology PMC - PMC4315435 OTO - NOTNLM OT - AOMP OT - AOSLO OT - MacTel type 2 OT - cone photoreceptors EDAT- 2015/01/15 06:00 MHDA- 2015/03/25 06:00 PMCR- 2015/08/01 CRDT- 2015/01/15 06:00 PHST- 2015/01/15 06:00 [entrez] PHST- 2015/01/15 06:00 [pubmed] PHST- 2015/03/25 06:00 [medline] PHST- 2015/08/01 00:00 [pmc-release] AID - iovs.14-15576 [pii] AID - 10.1167/iovs.14-15576 [doi] PST - epublish SO - Invest Ophthalmol Vis Sci. 2015 Jan 13;56(2):778-86. doi: 10.1167/iovs.14-15576.